Source: The Business Journals: San Francisco Business Times

Dermira: Months after $1 billion buyout, Peninsula company, Lilly face generic challenge

Perrigo wants to sell a lower-cost generic form of Qbrexza, a pre-moistened cloth that treats abnormally excessive sweating and was at the center of Eli Lilly's February acquisition of Dermira.

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Andrew Hotchkiss's photo - CEO of Dermira

CEO

Andrew Hotchkiss

CEO Approval Rating

81/100

Read more